Items tagged with Access

An Activist’s Guide to Shorter Treatment for Drug-Sensitive TB (post with simple image)

This new resource provides activists with information about two shorter treatment regimens for drug-sensitive TB, and equips them with actions they can take and arguments they can use to advocate for access to those regimens.

Hepatitis C and TB Long-Acting Medicines: Analysis of Patenting Trends and Implications for Access (post with simple image)

Treatment Action Group releases a patent landscape investigating potential patent barriers for the development and delivery of long-acting formulations for selected hepatitis C and TB medicines.

Advocates call on Unitaid to prioritise AIDS deaths and TB treatment in its investment and strategic plans (post with simple image)

Prioritising AIDS/advanced HIV disease and TB treatment in Unitaid’s Investment Plan and Strategic Framework for 2022-2026.

No Patents on Prevention! (post with simple image)

Can patents affect access to TB preventive treatment? - a community guidebook, produced by the ARK Foundation of Nagaland, India

Advocates call on Indian government to stop using injectable agents for the treatment of drug-resistant TB (post with simple image)

Advocates urge the Indian government to stop using kanamycin for the treatment of drug-resistant TB and instead scale up access to all oral regimens.

#RightToPreventTB campaign: TB preventive treatment is a human right! (post with simple image)

The #RightToPreventTB campaign focuses attention on the urgent need to scale-up TB preventive treatment as a matter of human rights.

Advocates demand immediate national roll out of 3HP in India (post with simple image)

Community monitoring mechanism highlights the gaps in the existing isoniazid preventive therapy program in the country and clearly indicates the high demand for 3HP.

Community-led monitoring for access to TB screening and diagnostic testing (post with simple image)

A tool, developed by the Coalition of Women Living with HIV and AIDS in partnership with Treatment Action Group, designed to equip communities to use community-lead monitoring to better understand the TB screening and diagnostic services, and to translate findings into evidence-based advocacy.

Activists across the world demand urgent action to improve access to lifesaving TB medicine, bedaquiline (post with simple image)

Communities affected by TB everywhere have a right to benefit from scientific progress, including access to short-course, bedaquiline-based treatment regimens for drug-resistant TB.

TB CAB 10-year anniversary evaluation report 2011–2021 and podcast (post with simple image)

In 2021, TB CAB celebrated its tenth anniversary of advocating for community engagement in research and improved access to TB prevention, treatment, and diagnostic technologies.

Page 72 of 73 · Total posts: 0

←First 71 72 73 Last→